Septalyst Lifesciences Private Limited

Septalyst Lifesciences Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U74900MH2010PTC203994 Incorporated 10 June 2010 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹51.21 Cr
▲ 28% YoY
Net profit · FY 2024
₹60.41 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹2.55 Cr
EBITDA margin 5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.25 Lakh
Issued & subscribed
Open charges
₹17.15 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
131
Provident fund records

About Septalyst Lifesciences Private Limited

Data last updated:

Septalyst Lifesciences Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 June 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2010PTC203994. Its GSTIN is 27AAOCS4959B1Z0 (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.25 Lakh. It is led by directors including Shyam Sunder Singh (Managing Director) and Bhaskar Shivprasad Mamgai.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 801 – 802 B Wing Lodha Supremus Kolshet Road Thane, Maharashtra, India – 400607.

As per the financials filed for FY 2024, the company reported a revenue of ₹51.21 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹60.41 Lakh (net margin 1.2%) and EBITDA of ₹2.55 Cr (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 7% over five years.

The company has about 131 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Septalyst. As per MCA filings, the company has open charges of ₹17.15 Cr on record. Court records list 8 cases involving the company, including 6 filed by the company and 2 filed against it; 4 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹3 Cr; the latest was in November 2022. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers.

Septalyst Lifesciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0041905). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website septalyst.com.

Company details

CIN U74900MH2010PTC203994
Registration Number 203994
Incorporation Date 10 June 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0041905
Key People
Shyam Sunder Singh Managing Director Bhaskar Shivprasad Mamgai Director Ajeet Singh Director

Recognitions & Rankings of Septalyst Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-33-0041905

Contact details

Septalyst Lifesciences Private Limited's registered office is in Thane, Maharashtra. Its website is septalyst.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    septalyst.com
  • Social Media
  • Registered Address
    801 – 802 B Wing Lodha Supremus Kolshet Road Thane, Maharashtra, India – 400607
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Septalyst Lifesciences Private Limited, buy the company report.

Comprehensive company report
Septalyst Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Septalyst Lifesciences operates one associated brand: Septalyst. Each brand links to its own profile.

BrandDescriptionWebsite
Septalyst
Development and distribution of pharmaceutical products for healthcare sectors in India.septalyst.com

Business activity

The main business activity of Septalyst Lifesciences is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Septalyst Lifesciences Private Limited, buy the company report.

Financials of Septalyst Lifesciences Private Limited

FY 2025 filings available

Septalyst Lifesciences Private Limited reported revenue of ₹51.21 Cr (up 28% YoY) for FY 2024.

Revenue · FY 2024
₹51.21 Cr ▲ 28%
Net profit · FY 2024
₹60.41 Lakh margin 1.2%
EBITDA · FY 2024
₹2.55 Cr margin 5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 11%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 12%
5 years · compounded
▼ 7%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 28% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹51.21 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.55 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹60.41 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Septalyst Lifesciences Private Limited, buy the company report.

Board of directors of Septalyst Lifesciences Private Limited

Septalyst Lifesciences has 5 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shyam Sunder SinghManaging Director10 Jun 201016 Years 4 MonthsCurrent
Bhaskar Shivprasad MamgaiDirector26 Oct 20215 Years 0 MonthsCurrent
Ajeet SinghDirector26 Oct 20215 Years 0 MonthsCurrent
Vishal Gourav BohidarDirector10 Jun 201016 Years 4 MonthsCurrent
Yogesh Prabhudyal SharmaDirector10 Jun 201016 Years 4 MonthsCurrent
View all directors

Auditor

Septalyst Lifesciences Private Limited is audited by R K KABRA & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
R K KABRA & ASSOCIATESFY 2024048271

Shareholding

The shareholding of Septalyst Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Septalyst Lifesciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.15 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹15.61 Cr
Hdfc Bank Limited₹1.54 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Jun 2025101116436Others₹4.9 CrOpen
02 Jun 2025101116433Others₹1.76 CrOpen
27 Jul 2022100623197Others₹6.5 CrOpen
27 Jul 2022100623198Others₹2.45 CrOpen
08 Feb 2021100436218Hdfc Bank Limited₹43.1 LakhOpen

To see the full charge records of Septalyst Lifesciences Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Septalyst Lifesciences Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹3 Cr; the latest was in November 2022.

Total deals
1
Funding round
1
Disclosed funding
₹3 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Nov 2022Funding round₹3 CrInvestors: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Septalyst Lifesciences Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Rivpra Formulation Private Limited
Iosis Remedies

To see the full MSME payment records of Septalyst Lifesciences Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Septalyst Lifesciences Private Limited has a workforce of 131 employees on its EPFO records as of Dec 16, 2024, across 1 active EPFO establishment.

Employee count
131
Active EPFO establishments
1
Employee growth
15.93%

GST

Septalyst Lifesciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAOCS4959B1Z0MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Septalyst Lifesciences Private Limited, buy the company report.

Recent activity

Septalyst Lifesciences Private Limited has 5 board changes on record since 2010: 5 appointments. The latest: Ajeet Singh was appointed as Director on 26 Oct 2021.

AGM
Septalyst Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 490.00 Lakh registered on 02 Jun 2025 with Charge ID 101116436 was modified on 29 Jul 2025.
Charges
A charge with Others of Rs. 176.20 Lakh registered on 02 Jun 2025 with Charge ID 101116433 was modified on 29 Jul 2025.
Charges
A charge with Others amounted to Rs. 490.00 Lakh with Charge ID 101116436 was registered on 02 Jun 2025.
Charges
A charge with Others amounted to Rs. 176.20 Lakh with Charge ID 101116433 was registered on 02 Jun 2025.
Filing
Septalyst Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 650.00 Lakh with Charge ID 100623197 was registered on 27 Jul 2022.
Charges
A charge with Others amounted to Rs. 245.00 Lakh with Charge ID 100623198 was registered on 27 Jul 2022.
Appointed
Ajeet Singh was appointed as Director.
Appointed
Bhaskar Shivprasad Mamgai was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 110.50 Lakh registered on 28 Jan 2021 with Charge ID 100422582 was modified on 12 Mar 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 43.10 Lakh with Charge ID 100436218 was registered on 08 Feb 2021.

5 earlier events are in the company report.

News

Frequently asked questions

Septalyst Lifesciences is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 June 2010 (16+ years old) and is registered under CIN U74900MH2010PTC203994.

Septalyst Lifesciences has 5 current directors:

The latest financial statements of Septalyst Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Septalyst Lifesciences is 27AAOCS4959B1Z0, registered in Maharashtra.

The CIN (Corporate Identification Number) of Septalyst Lifesciences is U74900MH2010PTC203994. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Septalyst Lifesciences has 8 court cases on record: 6 filed by the company and 2 filed against it. 4 are pending. Most are in the high courts.

Septalyst Lifesciences was incorporated on 10 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.

Septalyst Lifesciences has 1 deal on record (1 funding round), with disclosed funding of ₹3 Cr; the latest was in November 2022.

Ajeet Singh was appointed as Director on 26 Oct 2021. Bhaskar Shivprasad Mamgai was appointed as Director on 26 Oct 2021. Shyam Sunder Singh was appointed as Managing Director on 10 Jun 2010. Septalyst Lifesciences has 5 board changes on record in total.

Yes, Septalyst Lifesciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0041905).

Septalyst Lifesciences has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. The latest return was filed on 08 Jun 2019.